» Articles » PMID: 35115824

Transcranial Direct Current Stimulation Alleviates the Chronic Pain of Osteoarthritis by Modulating NMDA Receptors in Midbrain Periaqueductal Gray in Rats

Overview
Journal J Pain Res
Publisher Dove Medical Press
Date 2022 Feb 4
PMID 35115824
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Osteoarthritis (OA) is the most common cause to lead to chronic pain. Transcranial direct current stimulation (tDCS) has been widely used to treat nerve disorders and chronic pain. The benefits of tDCS for chronic pain are apparent, but its analgesic mechanism is still unclear. This study observed the analgesic effects of tDCS on OA-induced chronic pain and the changes of NMDA receptor levels in PAG after tDCS treatment in rats to explore the analgesic mechanism of tDCS.

Methods: After establishing chronic pain by injecting monosodium iodoacetate (MIA) into the rat ankle joint, the rats received tDCS for 14 consecutive days (20 min/day). Before tDCS treatment, Ifenprodil (the selective antagonist of NMDAR2B) was given to rats in different ways: intracerebroventricular (i.c.v.) injection or intraperitoneal (i.p.) injection. The Von Frey and hot plate tests were applied to assess the pain-related behaviors at different time points. The expression level of NMDAR2B was evaluated in midbrain periaqueductal gray (PAG) by Western blot. In addition, NMDAR2B and c-Fos were observed by the Immunohistochemistry staining after tDCS treatment.

Results: The mechanical allodynia and thermal hyperalgesia were produced after MIA injection. However, tDCS treatment reverted the mechanical allodynia and thermal hyperalgesia. Moreover, tDCS treatment significantly increased the expression of NMDAR2B and the proportion of positive stained cells of NMDAR2B. Besides that, the tDCS treatment also decreased the proportion of positive stained cells of c-Fos in PAG. However, these changes did not occur in the rats given the Ifenprodil (i.c.v.).

Conclusion: These results indicate that tDCS may increase the expression of NMDA receptors in PAG and strengthen the NMDA receptors-mediated antinociception to alleviate OA-induced chronic pain in rats.

Citing Articles

Modulating neuroplasticity for chronic pain relief: noninvasive neuromodulation as a promising approach.

Jayathilake N, Phan T, Kim J, Lee K, Park J Exp Mol Med. 2025; .

PMID: 40025172 DOI: 10.1038/s12276-025-01409-0.


Memantine attenuates the development of osteoarthritis by blocking NMDA receptor mediated calcium overload and chondrocyte senescence.

Cheng Q, He K, Zhu J, Li X, Wu X, Zeng C J Orthop Translat. 2024; 48:204-216.

PMID: 39280634 PMC: 11399475. DOI: 10.1016/j.jot.2024.08.007.


Mechanisms of transcranial direct current stimulation (tDCS) for pain in patients with fibromyalgia syndrome.

Wang S, Du S, Wang X, Lu J Front Mol Neurosci. 2024; 17:1269636.

PMID: 38356687 PMC: 10865494. DOI: 10.3389/fnmol.2024.1269636.


Anodal HD-tDCS on the dominant anterior temporal lobe and dorsolateral prefrontal cortex: clinical results in patients with mild cognitive impairment.

Rezakhani S, Amiri M, Hassani A, Esmaeilpour K, Sheibani V Alzheimers Res Ther. 2024; 16(1):27.

PMID: 38310304 PMC: 10837991. DOI: 10.1186/s13195-023-01370-y.


Transcranial Direct Current Stimulation Attenuates the Chronic Pain of Osteoarthritis in Rats via Reducing NMDAR2B Expressions in the Spinal Cord.

Liu Z, Chen X, Chen P, Wang L J Musculoskelet Neuronal Interact. 2023; 23(4):498-505.

PMID: 38037367 PMC: 10696371.


References
1.
Adachi L, Quevedo A, de Souza A, Scarabelot V, Rozisky J, de Oliveira C . Exogenously induced brain activation regulates neuronal activity by top-down modulation: conceptualized model for electrical brain stimulation. Exp Brain Res. 2015; 233(5):1377-89. DOI: 10.1007/s00221-015-4212-1. View

2.
Fields H, Malick A, Burstein R . Dorsal horn projection targets of ON and OFF cells in the rostral ventromedial medulla. J Neurophysiol. 1995; 74(4):1742-59. DOI: 10.1152/jn.1995.74.4.1742. View

3.
Jensen T, Yaksh T . The antinociceptive activity of excitatory amino acids in the rat brainstem: an anatomical and pharmacological analysis. Brain Res. 1992; 569(2):255-67. DOI: 10.1016/0006-8993(92)90637-o. View

4.
Nakazato E, Kato A, Watanabe S . Brain but not spinal NR2B receptor is responsible for the anti-allodynic effect of an NR2B subunit-selective antagonist CP-101,606 in a rat chronic constriction injury model. Pharmacology. 2004; 73(1):8-14. DOI: 10.1159/000081069. View

5.
Hu J, Wang Z, Guo Y, Zhang X, Xu Z, Liu S . A role of periaqueductal grey NR2B-containing NMDA receptor in mediating persistent inflammatory pain. Mol Pain. 2009; 5:71. PMC: 2803476. DOI: 10.1186/1744-8069-5-71. View